Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 29 of 47
  1. Ondansetron

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  2. Ondansetron

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  3. Ondansetron (ODFS)

    Aquestive Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  4. Ondansetron 8 mg ODFS without water

    Aquestive Therapeutics

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  5. Oral Fosmanogepix

    Basilea Pharmaceutica

    Healthy

    phase 1 small molecule completed

    1 trial
  6. Oxcarbazepine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  7. Oxytocin lower does (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Male

    phase 1 small molecule active

    1 trial
  8. Oxytocin nasal spray

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial
  9. Oxytocine and migraine

    Disc Medicine

    This is a study in healthy volunteers. We will study the trigeminovascular system, which is relevant in the pathophysiology of migraine.

    phase 1 other active

    1 trial
  10. PB016-01-02

    Lacuna Pharma Pty Ltd

    Not applicable, healthy volunteers

    phase 1 other active

    1 trial
  11. PC14586

    PMV Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  12. PCS499

    Processa Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial
  13. PEG-IFN alfa-2a BA-free formulation (Test)

    Hoffmann-La Roche

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. PF-03715455

    Pfizer

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. PF-07038124 or vehicle

    Pfizer

    Healthy

    phase 1 small molecule completed

    1 trial
  16. PF614

    Ensysce Biosciences

    Healthy

    phase 1 small molecule completed

    1 trial
  17. PF614

    Ensysce Biosciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. PKM23567

    Sanofi-aventis Healthcare Pty Ltd

    Healthy Volunteers

    phase 1 other active

    1 trial
  19. PL2200 fasted

    Protalix BioTherapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  20. PN-232

    Protagonist Therapeutics, Inc

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  21. PN-235

    Protagonist Therapeutics, Inc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  22. PN-881 Oral Solution

    Protagonist Therapeutics, Inc

    Healthy Volunteer

    phase 1 small molecule active

    1 trial
  23. PRAX-628

    Chongqing Precision Biotech Co., Ltd

    Healthy

    phase 1 small molecule active

    1 trial
  24. PRX-P4-003, (-)-FCF

    Praxis Precision Medicines

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.